Related Experiment Video
Updated: Dec 24, 2025
03:23
Author Spotlight: Investigating the Pathophysiology of Eosinophilic Esophagitis
Published on: May 10, 2024
1.2K
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part I
Milena Sokolowska1,2, G Enrico Rovati3, Zuzana Diamant4,5
1Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland.
Allergy
|April 13, 2020
Summary
Eicosanoids, like prostaglandins and leukotrienes, drive asthma and allergy symptoms. New research explores targeting these lipid mediators for improved treatments and clinical practice.
Area of Science:
- Immunology
- Biochemistry
- Pharmacology
Background:
- Eicosanoids (prostaglandins, leukotrienes, thromboxanes, lipoxins) are key lipid mediators in inflammation.
- Prostaglandins and leukotrienes are major contributors to airway pathophysiology in asthma and allergies.
- Current therapies target eicosanoid synthesis or receptor activity.
Purpose of the Study:
- To review current understanding of eicosanoid biology in human pathology.
- To highlight new findings relevant to clinical practice and novel therapeutics.
- To identify future research opportunities in eicosanoid-related diseases.
Main Methods:
- Literature review and synthesis of existing research.
- Expert consensus from a European Academy of Allergy and Clinical Immunology (EAACI) task force.
- Focus on clinical relevance and therapeutic development.
Main Results:
- Eicosanoids play a central role in asthma and allergic diseases.
- Targeting eicosanoids with inhibitors or antagonists shows therapeutic potential.
- Recent advances include prostaglandin D2 receptor antagonists.
Conclusions:
- Eicosanoid pathways are critical targets for managing allergic diseases.
- Further research into eicosanoid biology can lead to novel treatments.
- This review provides a foundation for future clinical and research endeavors.
Related Concept Videos
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
01:20Asthma: Pathogenesis and Management
1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
01:26Asthma-II: Pathophysiology and Classification
3.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.9K
01:30Asthma-IV: Diagnostic and Management
3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K
01:29Asthma-I: Introduction
3.3K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.3K
01:19Antiasthma Drugs: Leukotriene Modifiers
1.6K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.6K